A Study on the Correlation Between Cotinine Levels and Aneurysm Wall Enhancement on HRMRI.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorZhujiang Hospital
About this trial
This study aims to collect clinical, laboratory, and imaging data from patients with unruptured intracranial aneurysms, and collect blood or urine samples for cotinine testing. The enrolled patients underwent high-resolution magnetic resonance angiography to detect whether the intracranial aneurysm wall was enhanced and classify the degree of enhancement. The purpose is to study the correlation between arterial aneurysm wall enhancement and cotinine levels
Eligibility criteria
Qualifiers
Age 18-75 years old, male or infertile female;
Diagnosed as IA (intracranial aneurysm) through CTA, MRA, or DSA; And it is suitable for endovascular intervention treatment
The patient and/or their legal representative or guardian fully understand the research purpose, voluntarily participate and sign informed consent Books;
Patients willing to cooperate with high-resolution magnetic resonance imaging.
Disqualifiers
AVM (arteriovenous malformation), Moyamoya disease, or DAVF (dural arteriovenous fistula) related aneurysms;
Patients with contraindications for high-resolution magnetic resonance imaging;
Participants in clinical trials of other drugs or medical devices;
Patients with severe underlying diseases and extremely poor clinical conditions who cannot tolerate general anesthesia surgery;
Trial design
Treatments tested in this trial
- smoke
Treatment groups
450 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov